Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Can Kayatekin

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cell|October 24, 2017
A Genetic Tool to Track Protein Aggregates and Control Prion InheritanceGregory A Newby, Szilvia Kiriakov, Erinc Hallacli, et al.
Alimentary Pharmacology & Therapeutics|April 17, 2026
Affinity Proteomics-Based Non-Invasive Detection of Clinically Significant Liver DiseaseSriram Balasubramani, Katharina Remih, Anna Sophie Karl, et al.
Cell|March 13, 2018
Translocon Declogger Ste24 Protects against IAPP Oligomer-Induced ProteotoxicityCan Kayatekin, Audra Amasino, Giorgio Gaglia, et al.
Cells|March 10, 2022
Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral AdrenoleukodystrophyHongge Wang, Matthew D Davison, Martin L Kramer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
AAV gene therapy for GBA1-related diseasesSwathi Ayloo, Jae Cheon Ryu, Shih-Ching Chou, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2026
Accelerating Medicines Partnership® Parkinson's Disease Proteomics: A Comprehensive Resource for Advancing Parkinson's Disease ResearchVictoria J Dardov, Aparna Vasanthakumar, Ameya Kulkarni, et al.
Cell|June 10, 2022
The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stabilityErinc Hallacli, Can Kayatekin, Sumaiya Nazeen, et al.
NPJ Parkinson'S Disease|August 22, 2025
A brain-shuttled antibody targeting alpha synuclein aggregates for the treatment of synucleinopathiesSungwon An, John J McInnis, Dongin Kim, et al.
Iscience|September 2, 2025
Elovl1 inhibition reduced very long chain fatty acids in a mouse model of adrenoleukodystrophyJeremy Y Huang, Brian Freed, Martin Hanus, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cell|October 24, 2017
A Genetic Tool to Track Protein Aggregates and Control Prion InheritanceGregory A Newby, Szilvia Kiriakov, Erinc Hallacli, et al.
Alimentary Pharmacology & Therapeutics|April 17, 2026
Affinity Proteomics-Based Non-Invasive Detection of Clinically Significant Liver DiseaseSriram Balasubramani, Katharina Remih, Anna Sophie Karl, et al.
Cell|March 13, 2018
Translocon Declogger Ste24 Protects against IAPP Oligomer-Induced ProteotoxicityCan Kayatekin, Audra Amasino, Giorgio Gaglia, et al.
Cells|March 10, 2022
Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral AdrenoleukodystrophyHongge Wang, Matthew D Davison, Martin L Kramer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
AAV gene therapy for GBA1-related diseasesSwathi Ayloo, Jae Cheon Ryu, Shih-Ching Chou, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2026
Accelerating Medicines Partnership® Parkinson's Disease Proteomics: A Comprehensive Resource for Advancing Parkinson's Disease ResearchVictoria J Dardov, Aparna Vasanthakumar, Ameya Kulkarni, et al.
Cell|June 10, 2022
The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stabilityErinc Hallacli, Can Kayatekin, Sumaiya Nazeen, et al.
NPJ Parkinson'S Disease|August 22, 2025
A brain-shuttled antibody targeting alpha synuclein aggregates for the treatment of synucleinopathiesSungwon An, John J McInnis, Dongin Kim, et al.
Iscience|September 2, 2025
Elovl1 inhibition reduced very long chain fatty acids in a mouse model of adrenoleukodystrophyJeremy Y Huang, Brian Freed, Martin Hanus, et al.
Pageof 3